Evidence map›Paper›PMID 41823422›Full record

ArticleEndocrinology2026

Accessibility at a primed distal Fshb-Kcna4 super-enhancer is facilitated by Foxl2 during gonadotrope differentiation.

Tal Refael, Gil Golan, Daniella Darsa, Lilach Pnueli, Probir Chakravarty, Karine Rizzoti, Philippa Melamed

Abstract read
In one paragraph

Article in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tal RefaelFaculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Gil GolanFaculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Daniella DarsaFaculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Lilach PnueliFaculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel.
Probir ChakravartyBioinformatics Core, The Francis Crick Institute, London NW1 1AT, UK.
Karine RizzotiLaboratory of Stem Cell Biology and Developmental Genetics, The Francis Crick Institute, London NW1 1AT, UK.
Philippa MelamedFaculty of Biology, Technion-Israel Institute of Technology, Haifa 32000, Israel.ORCID 0000-0001-7814-6542

Funding

Cancer Research UK FC001107Francis Crick InstituteIsrael Ministry of Science, Technology and Space 2022-3Israel Ministry of Science, Technology and Space 2023-4Israel Ministry of Science, Technology and Space 2024-5Israel Ministry of Science, Technology and Space 2025-6Israel Science Foundation 334/23Levi Eshkol FellowshipRobin Lovell-BadgeWellcome Trust FC001107
6 · The paper itself

Abstract

A large "gene desert" located far upstream from Fshb and Kcna4 contains several gonadotrope-specific accessible chromatin sites that were seen in chromatin conformation capture to make distinct contacts with both genes. Expression of Fshb and Kcna4 was strongly inhibited by JQ-1, which represses super-enhancer activity, and the region displays super-enhancer characteristics. The sites of open chromatin were seen, in chromatin immunoprecipitation, to bind Brd4 and Med1, most notably at a site -67 kb from the Fshb gene, as well as binding Ctcf further upstream (-123 kb), all of which were increased following activin exposure. The locus is transcribed to chromatin-associated long noncoding RNAs whose levels correlate with Fshb and Kcna4 mRNA levels in vivo and in cultured gonadotrope cells, indicating coordinated regulation. CRISPR interference confirmed distinct functions for each element and, together with the chromatin conformation capture data, indicate that the -67 kb locus mediates basal and activin-stimulated Fshb expression, whereas the site at -59 kb contributes to activin-stimulation of both genes. Single-cell multiomics revealed that the -67 kb locus is accessible in pituitary stem cells and throughout gonadotrope differentiation, preceding opening of the Fshb promoter, although it is closed in other differentiated cell types, suggesting a gonadotrope-specific factor that keeps it open at this stage. Foxl2 was found to bind this element, contributes to maintaining its chromatin accessibility, and recruits Supt16h, a component of the Facilitates Active Chromatin Transcription histone chaperone complex. These findings define a distal, Foxl2-bound super-enhancer that regulates Fshb transcription and shapes the gonadotrope regulatory landscape.

Indexed as

Cell DifferentiationFollicle Stimulating Hormone, beta SubunitForkhead Box Protein L2Forkhead Transcription FactorsGonadotrophsAnimalsBromodomain Containing ProteinsCell Cycle ProteinsChromatinMediator Complex Subunit 1MiceNuclear ProteinsSuper EnhancersTranscription FactorsBrd4 protein, mouseBromodomain Containing ProteinsCell Cycle ProteinsChromatinFollicle Stimulating Hormone, beta SubunitForkhead Box Protein L2Forkhead Transcription FactorsFoxl2 protein, mouseMediator Complex Subunit 1Nuclear ProteinsTranscription FactorsenhancerFoxl2FshbgonadotropeKcna4transcription

Identifiers

PMID41823422
PMCPMC13070611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.